Correlation Between Aptevo Therapeutics and BioLineRx

Can any of the company-specific risk be diversified away by investing in both Aptevo Therapeutics and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptevo Therapeutics and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aptevo Therapeutics and BioLineRx, you can compare the effects of market volatilities on Aptevo Therapeutics and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptevo Therapeutics with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptevo Therapeutics and BioLineRx.

Diversification Opportunities for Aptevo Therapeutics and BioLineRx

0.57

Correlation Coefficient

Aptevo Therapeutics  BioLineRx

Very weak diversification

The 3 months correlation between Aptevo and BioLineRx is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Aptevo Therapeutics and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Aptevo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptevo Therapeutics are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Aptevo Therapeutics i.e., Aptevo Therapeutics and BioLineRx go up and down completely randomly.

Pair Corralation between Aptevo Therapeutics and BioLineRx

Given the investment horizon of 90 days Aptevo Therapeutics is expected to generate 2.87 times more return on investment than BioLineRx. However, Aptevo Therapeutics is 2.87 times more volatile than BioLineRx. It trades about -0.01 of its potential returns per unit of risk. BioLineRx is currently generating about -0.16 per unit of risk. If you would invest  44.00  in Aptevo Therapeutics on August 15, 2024 and sell it today you would lose (17.00) from holding Aptevo Therapeutics or give up 38.64% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Aptevo Therapeutics  vs.  BioLineRx

Aptevo Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aptevo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

BioLineRx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Aptevo Therapeutics and BioLineRx

The main advantage of trading using opposite Aptevo Therapeutics and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptevo Therapeutics position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.

The idea behind Aptevo Therapeutics and BioLineRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.